Article Information
PubMed
History
- Published online March 4, 2013.
Article Versions
- Latest version (November 26, 2012 - 08:19).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2013 Canadian Medical Association or its licensors
Author Information
- David G. Bailey, BScPhm PhD⇑,
- George Dresser, MD PhD,
- J. Malcolm O. Arnold, MB BCh MD
- From the Lawson Health Research Institute (Bailey), London, Ont.; the Department of Medicine (Arnold, Dresser) and the Divisions of Cardiology (Arnold) and Clinical Pharmacology (Dresser), Western University, London, Ont.
- Correspondence to:
David G. Bailey, david.bailey{at}lhsc.on.ca
Statistics from Altmetric.com
Cited By...
In this issue
Article tools
Respond to this article
Grapefruit–medication interactions: Forbidden fruit or avoidable consequences?
Jump to section
- Article
- What are the key scientific concepts of grapefruit–drug interactions?
- What determines which drugs are affected?
- What determines the clinical significance of the interaction?
- Who is at higher risk of grapefruit–drug interactions?
- What are examples of important grapefruit–drug interactions?
- Gaps in knowledge
- Conclusion
- Footnotes
- References
- Figures & Tables
- Related Content
- Responses
- Metrics
Related Articles
Cited By...
- Parallel evolution of UbiA superfamily proteins into aromatic O-prenyltransferases in plants
- Natural Products as Modulators of CES1 Activity
- Parallel evolution of UbiA superfamily proteins into aromatic O-prenyltransferases in plants
- Regional Proteomic Quantification of Clinically Relevant Non-Cytochrome P450 Enzymes along the Human Small Intestine
- Severity of coeliac disease and clinical management study when using a CYP3A4 metabolised medication: a phase I pharmacokinetic study
- Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug Interaction
- Citrus Consumption and Risk of Cutaneous Malignant Melanoma
- Assessment of a Candidate Marker Constituent Predictive of a Dietary Substance-Drug Interaction: Case Study with Grapefruit Juice and CYP3A4 Drug Substrates
- Identification of Diet-Derived Constituents as Potent Inhibitors of Intestinal Glucuronidation
- Grapefruit juice and clopidogrel
- Grapefruit juice and clopidogrel
- Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions
- Grapefruit-medication interactions
- Grapefruit-medication interactions
More in this TOC Section
Similar Articles
Collections
